Zhejiang Shapuaisi Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Zhejiang Shapuaisi Pharmaceutical Co Ltd cash flow-to-debt ratio. Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥8.57 Million could theoretically repay 0% of its total liabilities (CN¥513.25 Million) in one year. Check earnings quality score of Zhejiang Shapuaisi Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
Cash flow-to-debt ratio of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024. Historical debt coverage capacity for Zhejiang Shapuaisi Pharmaceutical Co Ltd across 17 annual periods. Check Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Zhejiang Shapuaisi Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2008–2024)
Zhejiang Shapuaisi Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2008 to 2024. Year-by-year debt coverage analysis for Zhejiang Shapuaisi Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhejiang Shapuaisi Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | CN¥25.67 Million | CN¥516.59 Million | ▼ -47.2% |
| 2023 | 0.09x | CN¥41.49 Million | CN¥440.92 Million | ▼ -80.4% |
| 2022 | 0.48x | CN¥115.72 Million | CN¥240.99 Million | ▲ +11.0% |
| 2021 | 0.43x | CN¥100.78 Million | CN¥232.89 Million | ▲ +260.0% |
| 2020 | 0.12x | CN¥44.09 Million | CN¥366.78 Million | ▼ -79.7% |
| 2019 | 0.59x | CN¥59.47 Million | CN¥100.28 Million | ▼ -1.1% |
| 2018 | 0.60x | CN¥100.37 Million | CN¥167.41 Million | ▲ +179.1% |
| 2017 | 0.21x | CN¥45.57 Million | CN¥212.13 Million | ▼ -81.9% |
| 2016 | 1.19x | CN¥294.33 Million | CN¥247.88 Million | ▲ +298.3% |
| 2015 | 0.30x | CN¥114.27 Million | CN¥383.37 Million | ▼ -78.0% |
| 2014 | 1.35x | CN¥147.99 Million | CN¥109.44 Million | ▲ +180.2% |
| 2013 | 0.48x | CN¥117.86 Million | CN¥244.26 Million | ▲ +73.8% |
| 2012 | 0.28x | CN¥67.27 Million | CN¥242.33 Million | ▲ +129.9% |
| 2011 | 0.12x | CN¥15.14 Million | CN¥125.43 Million | ▼ -51.6% |
| 2010 | 0.25x | CN¥17.57 Million | CN¥70.45 Million | ▼ -33.4% |
| 2009 | 0.37x | CN¥28.87 Million | CN¥77.15 Million | ▲ +131.4% |
| 2008 | 0.16x | CN¥11.20 Million | CN¥69.24 Million | — |